Discover Great Companies Discover Great Clients
Popularity  53.4万   |   Followers  773   |   Likes  129   |   Feedback  46 Claim this company

Making innovative antibody drugs accessible

No.14 Shenyang City Popularity Ranking No.2 Tiexi District No.23 Liaoning P No.1 Biological Products No.1 Biopharmaceuticals No.1 Biotechnology Pharmaceuticals No.1 Biotechnology Chemical No.1 Packaging Materials No.1 Sheng Chemical Pharmaceutical No.1 Biotechnology Chemistry No.1 Clinical Biotechnology Chemistry No.1 Pharmaceutical Technology No.1 Sheng Wu Ke Ji / Biotechnology Engineering No.1 Sheng Ming Ke Xue No.2 Yao Products R&D 国家高新技术企业 副会长单位 高新技术企业 常务理事单位 省级高新技术企业 国家知识产权示范企业 GMP认证
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 33年
  • Industry: Pharmaceutical/Biotechnology 、 Raw Materials and Processing
  • Full name: Shenyang Sunshine Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #14 in Shenyang City by popularity Ranked #1 in Shenyang Biological Products Company by popularity Ranked #1 in Shenyang Biopharmaceuticals Company by popularity Ranked #1 in Shenyang Biotechnology Pharmaceuticals Company by popularity Ranked #1 in Shenyang Biotechnology Chemical Company by popularity
  • Honors: 2025中国新经济500强 2023中国企业慈善公益500强 国家高新技术企业 副会长单位 According to algorithm
  • News: 2025-10-31:辉瑞+三生制药60亿合作,“撕开”全球肿瘤治疗新战场。
  • Salary: 50.6% of positions earn 8-15K, In 2026 vs last yeargrew by 6%.。Master's salary: ¥24.3K, Doctorate salary: ¥26.7K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 52.2%, "Computer/Network/Technology": 49.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 12.3%。
  • Recruiting: In 2026 vs 2025decreased by 26%. Demand for highly educated talent: Master's: 22, Doctorate: 8.
  • Requirement: Education: 本科 leads with 74.9%. Experience: 1-3年 leads with 40.3%.
  • Region: Distributed across 34 regions, 上海: 17.8%, 沈阳: 10.4%, 杭州: 9.2%, 北京: 7.2%.

About the Company

[Summary] Making innovative antibody drugs accessible

Shenyang Sunshine Pharmaceutical Co., Ltd. (hereinafter referred to as "Sunshine Company") was established in 1993, with a business scope covering the research, development, production, and sales of bioengineering products and biochemical drugs, as well as technical services for after-sales products. The company's Chinese name is "San Sheng" (Three Lives), reflecting the founders' aspiration to motivate themselves with the noble belief of "cherishing life, caring for survival, and creating a meaningful existence"; its English name is SUNSHINE, symbolizing "sunshine," embodying the great ideal of Sunshine employees to serve patients with "warmth and enthusiasm like sunshine" and benefit human society. The company is recognized as a High-Tech Enterprise by Shenyang Science and Technology Bureau and Liaoning Provincial Department of Science and Technology. In 1999, it was designated as a National Key High-Tech Enterprise by the Ministry of Science and Technology, and in 2001, it was recognized as a "National High-Tech Research and Development (863) Program Achievement Industrialization Base." The company's production facilities are located in Shenyang Economic and Technological Development Zone, covering an area of 48,000 square meters with a building area of 10,000 square meters, including three workshops for bacterial genetic engineering pharmaceuticals, cell genetic engineering pharmaceuticals, and preparation and packaging. All production workshops have passed the GMP certification of the State Food and Drug Administration (SFDA). The annual production capacity exceeds 10 million units, establishing the company as a relatively large-scale specialized biopharmaceutical production base in China. To date, the company has completed the development of four genetic engineering products: recombinant human thrombopoietin ("TPIAO," a national Class I new drug), recombinant human erythropoietin ("EPIAO"), recombinant human interferon alfa-2a ("INTEFEN"), and recombinant human interleukin-2 ("INLEUIN"), all of which are on the market and have achieved high market shares. Among them, "EPIAO" has consistently maintained the top position in sales volume and revenue, currently holding a market share of around 40%, making it a leading erythropoietin product with advanced technology, complete specifications, broad indications, and the highest market share. In 2005, the national Class I new drug recombinant human thrombopoietin ("TPIAO") was launched, which is a project under the national "863" Program and a major special topic of the "Tenth Five-Year" plan. Sunshine Company was the first in the world to industrialize this product and maintained a period of exclusive production advantage. The company's research institute possesses strong capabilities in product and technology development, having established an excellent new product research and development system. It has undertaken two National Torch Program projects and one "863" Program project, receiving multiple scientific research awards from national ministries, provincial, and municipal government departments. Currently, the company has six national invention patents either granted or in the process of application. While pursuing economies of scale to continuously reduce production costs and product prices, Sunshine Company has implemented comprehensive market cultivation and development strategies. Currently, it has established over 20 sales offices across the country, with a professional and high-quality marketing team, forming an efficient and orderly sales network mainly covering major cities, economically developed regions, and large and medium-sized hospitals. Sales performance has been steadily growing, and brand benefits continue to increase. On February 7, 2007, Sunshine Company was listed on the NASDAQ in the United States, becoming the first Chinese biotech and pharmaceutical enterprise to be directly listed on NASDAQ and the largest biotech IPO in the United States in nearly three years. As a leader in the domestic biopharmaceutical field, Sunshine Company will continue its unremitting efforts to maintain its leading position in production, research and development, and marketing, and will fully utilize its superior financial channels and sound commercial operations to expand the company's scale and open up international markets, thereby developing into a world-renowned biopharmaceutical enterprise. As a pioneer in China's genetic pharmaceutical industry, Sunshine employees are taking on the important task of awakening people's confidence in recovery and life awareness, and are willing to use their own light and enthusiasm to usher in the sunrise of China's genetic pharmaceutical industry as soon as possible!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Sunshine Pharmaceutical How Fast Is Hiring Growing? (203 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 34%
  • 2024: Up 327%
  • 2023: Up 983%
  • 2022: Down 97%
Sunshine Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Sunshine Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 1 Interns 8 Master's 22 Doctorate 8
No.194
Company Recruitment Ranking in Shenyang City 򀀩
No.1265
Recruitment Growth Ranking in Shenyang City 򀀩
No.37
Graduate Talent Ranking in Shenyang City 򀀩
No.4
Intern Talent Ranking in Shenyang City 򀀩
Note: How fast is hiring at Shenyang Sunshine Pharmaceutical Co., Ltd. growing? Sunshine Pharmaceutical2026: 823 openings (down 26%), 2025: 1117 openings (up 34%), 2024: 833 openings (up 327%), 2023: 195 openings (up 983%), 2022: 18 openings (down 97%), 2021: 579 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Sunshine Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 40%
  • 2024: Up 850%
  • 2023: Up 200%
  • 2022: Down 60%
Sunshine Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Shenyang Sunshine Pharmaceutical Co., Ltd. growing? Sunshine PharmaceuticalMaster's recruitment over the years: 2025: 80 openings (up 40%), 2024: 57 openings (up 850%), 2023: 6 openings (up 200%), 2022: 2 openings (down 60%), 2021: 5 openings. Sunshine Pharmaceutical master talent ranking in Shenyang: #19, Sunshine Pharmaceutical master salary mostly around 20-50K.

Sunshine Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
  • 2025: Up 67%
  • 2024: Up 200%
  • 2023: Up 200%
Sunshine Pharmaceutical Doctoral Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Shenyang Sunshine Pharmaceutical Co., Ltd. growing? Sunshine PharmaceuticalDoctorate recruitment over the years: 2026: 15 openings (flat), 2025: 15 openings (up 67%), 2024: 9 openings (up 200%), 2023: 3 openings (up 200%), 2022: 1 openings. Sunshine Pharmaceutical doctorate talent ranking in Shenyang: #8, Sunshine Pharmaceutical doctorate salary mostly around 15-50K.

Sunshine Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Shenyang Sunshine Pharmaceutical Co., Ltd.? Based on an analysis of Sunshine Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 52.2%, "Computer/Network/Technology": 49.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 12.3%, "Other (R&D and Technical)": 3.2%, "Scientific Research": 2.2%, "Art/Design/Creative": 1.1%. For reference only.

Sunshine Pharmaceutical — What Are the Salaries Like? (1002 records)

Manage
Sunshine Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 50.6% of roles pay ¥8-15K
Note: salary statistics are based on 1002 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shenyang Sunshine Pharmaceutical Co., Ltd.?Sunshine Pharmaceutical50.6% of positions earn 8-15K, Fresh graduate salary: ¥4.5K。Shenyang salary ranking top 10,销售类 average salary ¥14.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Sunshine Pharmaceutical

(More)
Are salaries high at Shenyang Sunshine Pharmaceutical Co., Ltd.? We provide: Information, 临床, Sales, RA, Pharmaceutical Sales Representative, Operations, Product Manager, Product Manager, Quality, Intern, 科学家, Analyst, QA, Project Manager, Finance Specialist, New Media Specialist, Senior Manager, Video Editor, 动画, 合规. Click to view detailed salary analysis by job.

Sunshine Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国新经济500强:

  • NO.246 2025中国新经济500强 >
  • NO.475 2024中国新经济500强 >
  • NO.362 2023中国新经济500强 >

Yes, ranked in 中国企业慈善公益500强:

  • NO.295 2023中国企业慈善公益500强 >
  • NO.24 2020中国企业慈善公益500强 >

Job Category

  • 销售类
    55.1% of total 55.1%
  • 医疗卫生/美容保健类
    52.2% of total 52.2%
  • 计算机/网络/技术类
    49.2% of total 49.2%
  • 生物/制药/化工/环保类
    12.2% of total 12.2%

Education

  • 本科
    74.9% of total 74.9%
  • 大专
    14.3% of total 14.3%
  • 硕士
    6.7% of total 6.7%
  • 博士
    1.8% of total 1.8%

Experience

  • 1-3年
    40.3% of total 40.3%
  • 不限
    32.3% of total 32.3%
  • 3-5年
    16.9% of total 16.9%
  • 5-10年
    9.9% of total 9.9%
View Detailed Analysis

What does Shenyang Sunshine Pharmaceutical Co., Ltd. require? Who is Sunshine Pharmaceutical hiring? Sunshine Pharmaceutical recruitment: 销售类占比最多占55.1%,其次是医疗卫生/美容保健类占52.2%. What education can get in at Sunshine Pharmaceutical? 本科占比最多占74.9%,其次是大专占14.3%. High education required at Sunshine Pharmaceutical? 硕士占6.7%,博士占1.8%. Work experience required at Sunshine Pharmaceutical? 1-3年占比最多占40.3%,其次是不限占32.3%. Where are the job locations at Sunshine Pharmaceutical? 上海占比最多占17.8%,其次是沈阳占10.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 100,000万(元)
Legal Representative: 靳征
Date Established:
Credit Code: 9121010660460338X6
Registered Address: 辽宁省沈阳市沈阳经济技术开发区十号路1甲3号

Partners & Suppliers

华润医药为三生制药药品分销商,覆盖医院及零售终端 Source
合作客户 医药商业/渠道
国药控股为三生制药提供药品分销及物流服务,三生制药通过其渠道销售药品 Source
合作客户 医药商业/渠道
上海医药为三生制药在上海及华东地区的药品分销商 Source
合作客户 医药商业/渠道
广东瑞远为三生制药供应包装材料,用于药品包装 Source
供应商 药用包装材料
采购重组人促红素等药品 Source
合作客户 化学制药

People who follow Sunshine Pharmaceutical also follow

Sunshine Pharmaceutical Competitors (Similar Companies)

“Managing health, creating brightness”
“The cradle and incubator of national chemical organic synthesis pharma”
医药 抗体 蛋白研究 生物医药
“Top five semiconductor equipment companies in China”
“Committed to becoming a trustworthy, respected, and influential excell”
“is a large state-owned enterprise group with cross-regional and divers”
医药流通 医药商业 医疗器械 产品分销
仪器/仪表 传感器 换热器 光学薄膜
“Specializing in the R&D, production, sales, and service of semiconduct”
服务外包 劳务派遣 人才测评 管理咨询
机械设备/装备 渣浆泵 矿山机械/设备 生产
“主要产品为碳纤维曲棍球”
“Committed to continuous innovation in biotechnology, providing product”
“Semiconductor integrated circuit design and manufacturing enterprise”
电动工具 电锤 电镐 夹具

Discover Great Companies, Discover Great Clients

沈阳公司名录 沈阳“Tiexi District”公司名录 沈阳“制药/药业”公司名录 沈阳“医药”公司名录 沈阳“生物医药”公司名录 沈阳“生物制药”公司名录 沈阳“生化药品”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates